ArticleslgStudy

science

Pardoprunox

Pardoprunox is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Pardoprunox rather than just read about it. In short: Pardoprunox (INN; code name SLV-308) is an antiparkinsonian drug developed by Solvay for the treatment of Parkinson's disease that reached phase III clinical trials before being discontinued.[1] It was also being investigated for the treatment of depression and anxiety but these indications appear to have been abandoned as well. Pardoprunox acts as a D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist (IA = 5…

Pardoprunox — main illustration
Pardoprunox — illustration

Key takeaways

  • Pardoprunox belongs to science; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Pardoprunox to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Pardoprunox from memory before moving on to harder problems.

Reference excerpt

Pardoprunox (INN; code name SLV-308) is an antiparkinsonian drug developed by Solvay for the treatment of Parkinson's disease that reached phase III clinical trials before being discontinued.[1] It was also being investigated for the treatment of depression and anxiety but these indications appear to have been abandoned as well. Pardoprunox acts as a D2 (pKi = 8.1) and D3 receptor (pKi = 8.6) partial agonist (IA = 50% and 67%, respectively) and 5-HT1A receptor (pKi = 8.5) full agonist (IA = 100%). It also binds to D4 (pKi = 7.8), α1-adrenergic (pKi = 7.8), α2-adrenergic (pKi = 7.4), and 5-HT7 receptors (pKi = 7.2) with lower affinity. Relative to other dopaminergic antiparkinsonian agents, pardoprunox is thought to have significantly less of a propensity for inducing certain side effects like dyskinesia and psychosis.

See also List of investigational Parkinson's disease drugs Aripiprazole Bifeprunox

References

Further reading Hauser RA, Bronzova J, Sampaio C, et al. (2009). "Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson's disease". European Neurology. 62 (1): 40–8. doi:10.1159/000216839. PMID 19407454. S2CID 39669742. Bronzova J, Sampaio C, Hauser RA, et al. (March 2010). "Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease". Movement Disorders. 25 (6): 738–746. doi:10.1002/mds.22948. PMID 20198713. S2CID 206241386.

Illustrations

Pardoprunox illustration

Worked examples

Example 1 — a first encounter with Pardoprunox

Start with the simplest possible case. Write down what Pardoprunox claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Pardoprunox before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Pardoprunox ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Pardoprunox

In research
Pardoprunox appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Pardoprunox in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Pardoprunox is common in secondary-school and first-year university syllabi. It links to neighbouring topics 5-HT1A agonists, Abandoned drugs, Alpha-1 blockers, so understanding it makes those chapters shorter.
In everyday life
Look for Pardoprunox outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Pardoprunox” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Pardoprunox in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Pardoprunox means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Pardoprunox out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Pardoprunox in simple terms?

Pardoprunox (INN; code name SLV-308) is an antiparkinsonian drug developed by Solvay for the treatment of Parkinson's disease that reached phase III clinical trials before being discontinued.[1] It was also being investigated for the treatment of depression and anxiety but these indications appear…

Why does Pardoprunox matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Pardoprunox?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Pardoprunox.

Tags

  • 5-HT1A agonists
  • Abandoned drugs
  • Alpha-1 blockers
  • Alpha-2 blockers
  • Benzoxazoles
  • Carbamates
  • D2 receptor agonists
  • D3 receptor agonists
  • Drugs not assigned an ATC code
  • Lactams
  • Lactones
  • Nervous system drug stubs

Keep exploring